» Articles » PMID: 39585164

Comparative Study of Injected Alzheimer's Disease Models in Rats: Insights from Experimental Research

Overview
Journal Pathophysiology
Publisher MDPI
Specialty Pathology
Date 2024 Nov 25
PMID 39585164
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) remains incurable, highlighting the need for new and diverse animal models to better understand its complex mechanisms. This study compares various injected animal models of AD, focusing on the main theories that explain the disease; Methods: Female Wistar rats (10-months old) were administered intracebroventricularly by artificial cerebrospinal fluid (aCSF) (Control), beta amyloid Aβ1-42 (BA), okadaic acid (OKA), lipopolysaccharides (LPS), buthionine sulfoximine (BSO) or by a mixture of these different molecules (MLG). Cognitive performance was assessed one week or one month after stereotaxic surgery; Results: Our results, show that only the Aβ and the MLG induced a persistence and progressive deficits in the working memory, recognition memory and spatial memory in rats. As the hippocampus (HIP) and the prefrontal cortex (PFC) are particularly involved in memory behavior, we analyzed long-term neuroadaptations in these brain subregions using spectrophotometric and histological methods to assess oxidative stress changes and neuronal loss, respectively. We found that the behavioral impairments in memory and learning were accompanied by irreversible oxidative stress changes and neurodegenerescence, particularly in the HIP; Conclusions: This study provides promising data on the modeling of AD in order to develop an effective therapeutic approach.

References
1.
Guilloux J, Seney M, Edgar N, Sibille E . Integrated behavioral z-scoring increases the sensitivity and reliability of behavioral phenotyping in mice: relevance to emotionality and sex. J Neurosci Methods. 2011; 197(1):21-31. PMC: 3086134. DOI: 10.1016/j.jneumeth.2011.01.019. View

2.
Perluigi M, Di Domenico F, Butterfield D . Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease. Physiol Rev. 2023; 104(1):103-197. PMC: 11281823. DOI: 10.1152/physrev.00030.2022. View

3.
Chen Y, Fu A, Ip N . Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies. Pharmacol Ther. 2018; 195:186-198. DOI: 10.1016/j.pharmthera.2018.11.006. View

4.
Coria-Lucero C, Castro A, Ledezma C, Leporatti J, Ramirez D, Ghersi M . An intracerebroventricular injection of AΒ (1-42) modifies temporal profiles of spatial memory performance and oxidative status in the temporal cortex rat. Brain Res. 2023; 1804:148242. DOI: 10.1016/j.brainres.2023.148242. View

5.
Zakaria R, Wan Yaacob W, Othman Z, Long I, Ahmad A, Al-Rahbi B . Lipopolysaccharide-induced memory impairment in rats: a model of Alzheimer's disease. Physiol Res. 2017; 66(4):553-565. DOI: 10.33549/physiolres.933480. View